From today, GPs across England can prescribe weight loss injections on the NHS, with the initial rollout of Mounjaro targeted at around 220,000 adults with the greatest medical need.
As part of a phased introduction, only individuals with a body mass index (BMI) over 40 and at least four obesity-related health conditions will qualify for the weight loss jab in the first year.
The move marks a major shift in NHS obesity treatment in the UK, with Mounjaro previously available only via specialist clinics or private prescriptions.
Health officials have advised that the injections are not suitable for women who are pregnant, trying to conceive, or breastfeeding.
While the initiative has been welcomed by many, some GPs have raised concerns about additional workload, and pharmacists warn of potential supply shortages. With over 1.5 million Britons currently using weight loss medication, demand is expected to increase sharply.
NHS England: “We Must Tackle Rising Obesity Rates”
Dr Claire Fuller of NHS England stated: “We urgently need to address rising levels of obesity and prioritise those suffering from severe health complications. Increasing access to weight loss treatments like Mounjaro will significantly improve patients’ quality of life.”
She stressed the importance of patients discussing the full range of NHS weight management services with their GP, as not everyone will meet the eligibility requirements for the injections.
RCGP and Pharmacists Call for Holistic Approach
Professor Kamila Hawthorne, Chair of the Royal College of General Practitioners, backed the phased rollout but cautioned that weight loss jabs are not a ‘silver bullet’.
“These medications can offer vital support to patients who meet the clinical criteria, but prevention must remain a key focus. Addressing the root causes of obesity is essential.”
Her views were echoed by Olivier Picard, Chair of the National Pharmacy Association, who emphasised the need for a comprehensive strategy combining medication with lifestyle changes.
“Prescribing injections without support for diet and exercise risks short-term gains followed by rebound weight gain. Many GPs simply lack the time to deliver this broader care.”
Government Commits to Wider Access
Health Secretary Wes Streeting reaffirmed the government’s commitment to tackling health inequality, stating:
“We are determined to bring these cutting-edge obesity treatments to everyone who needs them—not just those who can afford private care.”
With approximately 29% of UK adults now classified as obese, the government’s move to expand access to NHS-prescribed weight loss treatments is seen as a critical step in addressing the UK’s obesity crisis.
